121 related articles for article (PubMed ID: 2540746)
1. Characterization of specific binding sites for PAF in the iris and ciliary body of rabbit.
Domingo MT; Chabrier PE; Van Delft JL; Verbeij NL; Van Haeringen NJ; Braquet P
Biochem Biophys Res Commun; 1989 Apr; 160(1):250-6. PubMed ID: 2540746
[TBL] [Abstract][Full Text] [Related]
2. Specific receptor sites for PAF in iris and ciliary body of the rabbit eye.
van Delft JL; van Haeringen NJ; Verbeij NL; Domingo MT; Chabrier PE; Braquet P
Curr Eye Res; 1988 Nov; 7(11):1063-8. PubMed ID: 2854038
[TBL] [Abstract][Full Text] [Related]
3. Presence of specific platelet-activating factor binding-sites in neuroblastoma N1E-115 cells.
Lalouette F; Diserbo M; Martin C; Verdetti J; Fatome M
Neurosci Lett; 1995 Feb; 186(2-3):173-6. PubMed ID: 7777190
[TBL] [Abstract][Full Text] [Related]
4. PAF binding sites. Characterization by [3H]52770 RP, a pyrrolo[1,2-c]thiazole derivative, in rabbit platelets.
Robaut C; Durand G; James C; Lave D; Sedivy P; Floch A; Mondot S; Pacot D; Cavero I; Le Fur G
Biochem Pharmacol; 1987 Oct; 36(19):3221-9. PubMed ID: 2822048
[TBL] [Abstract][Full Text] [Related]
5. Ginkgolides and platelet-activating factor binding sites.
Hosford DJ; Domingo MT; Chabrier PE; Braquet P
Methods Enzymol; 1990; 187():433-46. PubMed ID: 2172741
[No Abstract] [Full Text] [Related]
6. Species difference in the specific receptors of platelet activating factor.
Hwang SB; Lam MH
Biochem Pharmacol; 1986 Dec; 35(24):4511-8. PubMed ID: 3024653
[TBL] [Abstract][Full Text] [Related]
7. Reversible or irreversible modification of [3H]PAF binding on rabbit platelet membranes differentiates various PAF receptor antagonists.
Domingo MT; Piro F; Broquet C; Auclair E; Chabrier PE; Braquet P
Lipids; 1992 Aug; 27(8):582-6. PubMed ID: 1328798
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of transmembrane movement and metabolism of platelet activating factor (PAF-acether) by a specific antagonist, BN 52021.
Lachachi H; Plantavid M; Simon MF; Chap H; Braquet P; Douste-Blazy L
Biochem Biophys Res Commun; 1985 Oct; 132(2):460-6. PubMed ID: 2998370
[TBL] [Abstract][Full Text] [Related]
9. Comparison of three paf-acether receptor antagonist ginkgolides.
Korth R; Nunez D; Bidault J; Benveniste J
Eur J Pharmacol; 1988 Jul; 152(1-2):101-10. PubMed ID: 2850196
[TBL] [Abstract][Full Text] [Related]
10. Presence of specific binding sites for platelet-activating factor (PAF) in brain.
Domingo MT; Spinnewyn B; Chabrier PE; Braquet P
Biochem Biophys Res Commun; 1988 Mar; 151(2):730-6. PubMed ID: 2831903
[TBL] [Abstract][Full Text] [Related]
11. [Effect of platelet activating factor receptor at spinal cord neurocyte membrane on secondary damage after spinal cord injury].
Xiao J; Zhao D; Jia L
Zhonghua Yi Xue Za Zhi; 1996 Feb; 76(2):120-3. PubMed ID: 8758444
[TBL] [Abstract][Full Text] [Related]
12. Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds.
Baroggi N; Etienne A; Braquet P
Agents Actions Suppl; 1986; 20():87-97. PubMed ID: 3028108
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021.
Kurihara K; Wardlaw AJ; Moqbel R; Kay AB
J Allergy Clin Immunol; 1989 Jan; 83(1):83-90. PubMed ID: 2536413
[TBL] [Abstract][Full Text] [Related]
14. Role of platelet-activating factor in long-term potentiation of the rat medial vestibular nuclei.
Grassi S; Francescangeli E; Goracci G; Pettorossi VE
J Neurophysiol; 1998 Jun; 79(6):3266-71. PubMed ID: 9636125
[TBL] [Abstract][Full Text] [Related]
15. Presence of specific platelet-activating factor binding sites in the rat retina.
Thierry A; Doly M; Braquet P; Cluzel J; Meyniel G
Eur J Pharmacol; 1989 Apr; 163(1):97-101. PubMed ID: 2545464
[TBL] [Abstract][Full Text] [Related]
16. Pharmacologic characterization of the rabbit neutrophil receptor for platelet-activating factor.
Paulson SK; Wolf JL; Novotney-Barry A; Cox CP
Proc Soc Exp Biol Med; 1990 Nov; 195(2):247-54. PubMed ID: 2172997
[TBL] [Abstract][Full Text] [Related]
17. Prehispanolone, a novel platelet activating factor receptor antagonist from Leonurus heterophyllus.
Lee CM; Jiang LM; Shang HS; Hon PM; He Y; Wong HN
Br J Pharmacol; 1991 Jul; 103(3):1719-24. PubMed ID: 1657264
[TBL] [Abstract][Full Text] [Related]
18. [Platelet-activating factor (PAF) antagonists].
Terasawa M
Tanpakushitsu Kakusan Koso; 1991 Feb; 36(3):379-87. PubMed ID: 1850862
[No Abstract] [Full Text] [Related]
19. The accumulation of platelet activating factor in the injured cornea may be interrelated with the synthesis of lipoxygenase products.
Bazan HE; Reddy ST; Woodland JM; Bazan NG
Biochem Biophys Res Commun; 1987 Dec; 149(3):915-20. PubMed ID: 2827658
[TBL] [Abstract][Full Text] [Related]
20. Characterization of receptors for platelet-activating factor on platelets, polymorphonuclear leukocytes and macrophages.
Stewart AG; Dusting GJ
Br J Pharmacol; 1988 Aug; 94(4):1225-33. PubMed ID: 2850058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
